Lupin Ranibizumab intravitreal injection gets CDSCO Panel nod for Phase IV study Dr. Divya Colin25 Oct 2022 10:45 AM ISTNew Delhi: Pharmaceuticals major Lupin has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Novartis Gets CDSCO Panel Nod To Study Crizanlizumab Dr. Divya Colin18 Aug 2022 6:00 PM ISTNew Delhi: Pharmaceutical major Novartis has got a green signal from the Subject Expert Committee (SEC) functional under the Central Drugs Standard...
Sun Pharma secures CDSCO Panel nod to conduct phase IV Trial of Atropine Sulfate Ophthalmic Solution Medical Dialogues Team9 July 2021 6:17 PM ISTNew Delhi: Pharmaceutical major Sun Pharma has recently secured permission from the Subject Expert Committee (SEC) of the Central Drugs Standard...
Glenmark gets CDSCO panel nod to revise phase 4 protocol for Minocycline Hydrochloride Topical Gel Medical Dialogues Team16 Jun 2021 9:30 AM ISTNew Delhi: Responding to the phase IV protocol for Minocycline Hydrochloride Topical Gel 4% for topical use presented by Glenmark Pharma, the Subject...
Entod Pharma directed to submit results of Phase-IV CT protocol on 25 patients to continue manufacturing Cataract FDC Medical Dialogues Team7 March 2021 12:30 PM ISTNew Delhi: Manufacturer of fixed-dose combination drug Tropicamide/Phenylephrine/Lidocaine Intracameral solution for injection (0.2mg/ml + 3.1mg/ml +...
Wockhardt secures CDSCO panel conditional nod to conduct Phase IV Trial of Levonadifloxacin MD Bureau6 Jan 2021 6:18 PM ISTNew Delhi: Pharmaceutical and biotechnology major Wockhardt Ltd. has recently secured permission from the Subject Expert Committee (SEC) of the...
